Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial. - Krop IE; Mittempergher L; Paulson JN; Andre F; Bonnefoi H; Loi S; Loibl S; Gelber RD; Caballero C; Bhaskaran R; Dreezen C; Menicucci AR; et al. (JCO precision oncology, 2024)